Evaluation of health status in patients with hepatitis c treated with and without interferon
Author:
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,General Medicine
Link
http://link.springer.com/content/pdf/10.1186/s12955-018-0842-x.pdf
Reference37 articles.
1. Chhatwal J, Kanwal F, Roberts MS, Dunn MA. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. Ann Intern Med. 2015;162(6):397–406. https://doi.org/10.7326/M14-1336 .
2. Najafzadeh M, Andersson K, Shrank WH, Krumme AA, Matlin OS, et al. Cost-effectiveness of novel regimens for the treatment of hepatitis C virus. Ann Intern Med. 2015;162(6):407–19. https://doi.org/10.7326/M14-1152.
3. Shepherd J, Jones J, Hartwell D, Davidson P, Price A, Waugh N. Interferon alpha (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation. Health Technol Assess. 2007;11(11):1–205. iii
4. Cortesi PA, Scalone L, Mantovani LG. Cost-effectiveness Analysis of new drugs for chronic hepatitis C: the importance of updating utility values. Hepatology. 2015;61(3):1096–7.
5. Croce D, Bonfanti M, Restelli U. Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives. Clinicoecon Outcomes Res. 2016;8:377–85. https://doi.org/10.2147/CEOR.S106769 .
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The influence of prehabilitation in patients with liver cirrhosis before liver transplantation: a randomized clinical trial;European Journal of Physical and Rehabilitation Medicine;2023-12
2. Health-related Quality of Life in Patients with Liver Cirrhosis: Its Determination and Correlation with Relevant Factors;Journal of Liaquat University of Medical & Health Sciences;2023-09-18
3. Comparison of the quality of life of patients with liver cirrhosis before and during the COVID-19 lockdown in Slovakia;Scientific Reports;2023-02-11
4. Kronik Hepatit C Hastalarında Uygulanan Direkt Etkili Antiviral Tedavinin Yaşam Kalitesi Üzerine Uzun Dönem Etkisinin Değerlendirilmesi;Medical Journal of Western Black Sea;2022-12-27
5. Intentions Regarding COVID-19 Vaccination in Females Aged 15–49 Years;Vaccines;2022-02-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3